Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
1,4-SUBSTITUTED PIPERAZINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2006/109817
Kind Code:
A1
Abstract:
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein R1 represents a branched alkyl group having 3 to 9 carbon atoms or the like; R2 represents a 6-membered heteroaryl group having 1 or 2 nitrogen atoms or the like; R3 represents a hydrogen atom, an alkanoylamino group or the like; R4 represents a hydrogen atom, a lower alkyl group or the like; X1 represents an oxygen or sulfur atom; X2 represents an oxygen atom or a single bond; and m is an integer of 0 to 4. This compound has a metabotropic glutamate receptor 1 inhibitory effect, and therefore is useful for the treatment of a brain disorder such as convulsion, acute pain, inflammatory pain, chronic pain, cerebral infraction or transient cerebral ischemic attack, a mental dysfunction such as schizophrenia, and a disease such as anxiety and drug addiction.

Inventors:
SATOH ATSUSHI (JP)
KAWAMOTO HIROSHI (JP)
KIMURA TOSHIFUMI (JP)
SUZUKI GENTAROH (JP)
SATO AKIO (JP)
OHTA HISASHI (JP)
Application Number:
PCT/JP2006/307691
Publication Date:
October 19, 2006
Filing Date:
April 05, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BANYU PHARMA CO LTD (JP)
SATOH ATSUSHI (JP)
KAWAMOTO HIROSHI (JP)
KIMURA TOSHIFUMI (JP)
SUZUKI GENTAROH (JP)
SATO AKIO (JP)
OHTA HISASHI (JP)
International Classes:
C07D213/74; A61K31/496; A61K31/501; A61K31/506; A61P1/00; A61P9/10; A61P25/04; A61P25/08; A61P25/16; A61P25/22; A61P25/28; A61P25/30; C07D213/75; C07D213/79; C07D213/84; C07D237/20; C07D239/42; C07D249/08; C07D263/58; C07D271/06; C07D277/20; C07D277/42; C07D401/04; C07D413/04; C07D417/04
Domestic Patent References:
WO2004014370A22004-02-19
WO2003093236A12003-11-13
WO2006004142A12006-01-12
Other References:
CHILMONCZYK Z. ET AL.: "Synthesis, Pharmacological Properties and SAR of New 1,4-Disubstituted Piperazine Derivatives with Hypnotic-Sedative Activity", POLISH JOURNAL OF CHEMISTRY, vol. 78, no. 8, 2004, pages 1027 - 1037, XP003005833
MA Z. ET AL.: "Synthesis of acylates of nitridazole and its analogs as schistosomicides", YAOXUE XUEBAO, vol. 24, no. 6, 1989, pages 476 - 480, XP003005834
JI J. ET AL.: "Selective Amination of Polyhalopyridines Catalyzed by a Palladium-Xantphos Complex", ORGANIC LETTERS, vol. 5, no. 24, 2003, pages 4611 - 4614, XP003005835
EVINDAR G. ET AL.: "Copper- and Palladium-Catalyzed Intramolecular Aryl Guanidinylation: An Efficient Method for the Synthesis of 2-Aminobenzimidazoles", ORGANIC LETTERS, vol. 5, no. 2, 2003, pages 133 - 136, XP002373113
ROMERO D.L. ET AL.: "Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 7, 1994, pages 999 - 1014, XP002186760
HONG Y. ET AL.: "Palladium catalyzed amination of 2-chloro-1,3-azole derivatives: mild entry to potent H1-antihistaminic norastemizole", TETRAHEDRON LETTERS, vol. 38, no. 32, 1997, pages 5607 - 5610, XP002387468
JOYCE L.L. ET AL.: "Copper- and palladium-catalyzed intramolecular C-S bond formation: a convenient synthesis of 2-aminobenzothiazoles", CHEMICAL COMMUNICATIONS, vol. 4, 2004, pages 446 - 447, XP003005836
Attorney, Agent or Firm:
BANYU PHARMACEUTICAL CO., LTD. (Kudan-kita 1-chome Chiyoda-k, Tokyo 67, JP)
Download PDF: